Editorial: Obesity and diabetes: implications for brain-immunometabolism, volume II.

Front Neurosci

Department of Experimental Medical Science, Faculty of Medicine, Lund University, Lund, Sweden.

Published: October 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580065PMC
http://dx.doi.org/10.3389/fnins.2023.1244064DOI Listing

Publication Analysis

Top Keywords

editorial obesity
4
obesity diabetes
4
diabetes implications
4
implications brain-immunometabolism
4
brain-immunometabolism volume
4
editorial
1
diabetes
1
implications
1
brain-immunometabolism
1
volume
1

Similar Publications

The rise in global obesity prevalence has increased the need to understand the pharmacokinetics of drugs in overweight and obese individuals. Tuberculosis remains a significant health challenge, and its treatment outcomes can be influenced by the pharmacokinetic profiles of antitubercular agents. This literature review aims to point out the clinical pharmacokinetics of antitubercular drugs in the overweight and obese patient population, highlighting considerations for potential dosage adjustments.

View Article and Find Full Text PDF

The obesity rate is increasing worldwide despite various policies and efforts. However, there is a concern with underrecording and underreporting of obesity in outpatient and inpatient settings which can affect patient care. Local and national reports based on medical records can provide an underestimated rate of obesity.

View Article and Find Full Text PDF

Food Insecurity and Poor Health: Unraveling the Mechanisms, Informing Better Solutions.

Circ Cardiovasc Qual Outcomes

January 2025

Food is Medicine Institute, Friedman School of Nutrition Science and Policy, and Tufts University School of Medicine, Tufts University, Boston, MA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!